Paul R. Carlier
Co-chair, Antimicrobial Countermeasures (vaccine/drug) thematic focus, Center for Emerging, Zoonotic, and Anthropod-borne Pathogens (CeZAP), Virginia Tech
Professor Paul Carlier
I trained as a synthetic organic chemist in the laboratory of K. Barry Sharpless (2001 Nobel Prize in Chemistry). After a brief stint in industry, my academic career began with a first appointment as founding faculty at the Hong Kong University of Science and Technology (HKUST). During my 9 years there I was promoted to Associate Professor and began two productive collaborations on memory-enhancers for Alzheimer’s disease and new therapies for SSRI-resistant depression. In 2000 I moved to Virginia Tech, where I continued my research in stereoselective synthesis and CNS drug discovery. Since 2005, my laboratory has focused on the design, synthesis, and pharmacological evaluation of small molecules to address critical challenges in global health, particularly malaria.